Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 1026 to 1050 of 2559

TitleReference numberPublishedLast updated
Pembrolizumab with axitinib for untreated advanced renal cell carcinomaTA650
Naldemedine for treating opioid-induced constipationTA651
Novii Wireless Patch System for maternal and fetal monitoringMIB228
Transcranial magnetic stimulation for auditory hallucinationsHTG555
Polatuzumab vedotin with rituximab and bendamustine for treating relapsed or refractory diffuse large B-cell lymphomaTA649
t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetesMIB227
Neuropathic pain in adults: pharmacological management in non-specialist settingsCG173
Insect bites and stings: antimicrobial prescribingNG182
Axonics sacral neuromodulation system for treating refractory overactive bladderHTG554
Implantable cardiac monitors to detect atrial fibrillation after cryptogenic strokeHTG553
Glasdegib with chemotherapy for untreated acute myeloid leukaemia (terminated appraisal)TA646
Eculizumab for treating relapsing neuromyelitis optica (terminated appraisal)TA647
Helge for detecting haemolysisMIB225
Community pharmacies: promoting health and wellbeingQS196
Faltering growthQS197
FebriDx for C-reactive protein and myxovirus resistance protein A testingMIB224
High-sensitivity troponin tests for the early rule out of NSTEMIHTG552
Surgical site infections: prevention and treatmentNG125
Perioperative care in adultsNG180
Rehabilitation for adults with complex psychosisNG181
Deep brain stimulation for refractory epilepsy in adultsHTG550
Implanted vagus nerve stimulation for treatment-resistant depressionHTG551
Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphomaTA641
Gilteritinib for treating relapsed or refractory acute myeloid leukaemiaTA642
Entrectinib for treating ROS1-positive advanced non-small-cell lung cancerTA643

Results per page

  1. 10
  2. 25
  3. 50
  4. All